Home » Topics » Conferences

Conferences
RSS

Thalidomide: Forty years later

Jan. 30, 1997

Cidofovir highlighted at retroviral conference

Jan. 30, 1997

Pilot trial of folic acid in stroke patients

Jan. 30, 1997

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Encouraging results reported for Merck anti-HIV combination

Jan. 30, 1997

Triple combination therapy dramatically effective in HIV/AIDS

Jan. 30, 1997

Doxil superior to other treatments for first-line treatment of Kaposi's sarcoma

Jan. 29, 1997

Combination HIV-IG/MAbs shows synergistic anti-HIV effects

Jan. 28, 1997

Preliminary results for potential new anti-HIV combination presented

Jan. 28, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...